-
公开(公告)号:US07348009B1
公开(公告)日:2008-03-25
申请号:US09554860
申请日:1998-11-16
CPC分类号: C07K14/43531 , C12N9/6472
摘要: The present invention provides a novel treatment for allergy comprising a recombinant allergen with reduced enzymatic activity, thereby reducing the potential for an allergic response upon contact with a wild-type allergen.
摘要翻译: 本发明提供了包含具有降低的酶活性的重组变应原的变态反应的新型治疗,从而降低了与野生型变应原接触时过敏反应的可能性。
-
公开(公告)号:US07173117B2
公开(公告)日:2007-02-06
申请号:US10297563
申请日:2001-06-07
CPC分类号: C07K14/43531 , A61K38/00
摘要: The present invention relates to codon optimised polynucleotides which are efficiently expressed in mammalian cells and encode insect proteins from Dermaphagoids dust mite. In particular, the optimised codon polynucleotides encode a protein from Dermaphagoides pteronyssinus, such as DerP1 or proDerP1. The present invention also provides methods of preparing pharmaceutical compositions comprising the expression of the codon optimised polynucleotides, and vectors and transformed host cells comprising them.
摘要翻译: 本发明涉及密码子优化的多核苷酸,其在哺乳动物细胞中有效表达并编码来自皮肤螨类的昆虫蛋白质。 特别地,优化的密码子多核苷酸编码来自Dermaphagoides pteronyssinus的蛋白质,例如DerP1或proDerP1。 本发明还提供了制备包含密码子优化的多核苷酸表达的药物组合物的方法,以及包含它们的载体和转化的宿主细胞。
-